Even as it’s become clear that an inherited susceptibility to some cancers is more common than once thought, genetic testing of family members of cancer patients hasn’t increased as much as experts had hoped.
Impact of Recombinant Replacement Therapy Detailed in Genetic Clotting Disorder
A recombinant replacement for the ADAMTS13 protein (Adzynma) missing in congenital thrombotic thrombocytopenic purpura (TTP) restored levels and reduced acute TTP events, according to interim